Ulthera Overview

  • Founded
  • 2004
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 166
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $600M
Latest Deal Amount

Ulthera General Information

Description

Developer of ultrasound based medical devices. The company offers a nonsurgical cosmetic procedure employing therapeutic ultrasound technology that is used to counter the affects of aging on the skin through tightening and lifting skin tissues.

Contact Information

Website
www.ulthera.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Diagnostic Equipment
Parent Company
Merz North America
Primary Office
  • 1840 South Stapley Drive
  • Suite 200
  • Mesa, AZ 85204
  • United States
+1 (877) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ulthera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 30-Jul-2014 $600M 000.00 00000 Completed Generating Revenue
4. IPO 27-Jun-2014 000.00 Cancelled Generating Revenue
3. Later Stage VC (Series C) 08-Feb-2011 000.00 000.00 000.00 Completed Generating Revenue
2. Later Stage VC (Series B) 17-Jan-2008 $22.5M $28M 000.00 Completed Generating Revenue
1. Later Stage VC (Series A) 13-Dec-2005 $5.5M $5.5M 000.00 Completed Product Development
To view Ulthera’s complete valuation and funding history, request access »

Ulthera Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A 2,750,000 $0.001000 8% $2 $2 1x $1.33 8.43%
To view Ulthera’s complete cap table history, request access »

Ulthera Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of ultrasound based medical devices. The company offers a nonsurgical cosmetic procedure employing therapeutic
Therapeutic Devices
Mesa, AZ
166 As of 2014
000.00
0000 0000-00-00
000000&0 000.00

00000000

qua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commod
00000000000 0000000
Saint Paul, MN
000 As of 0000
00.00
000000&0 00.00

0000000

re eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui offic
00000000000 0000000
Largo, FL
00 As of 0000
00.000
000000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ulthera Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
RespirTech Formerly PE-Backed Saint Paul, MN 000 00.00 000000&0 00.00
0000000 Private Equity-Backed Largo, FL 00 00.000 000000000000 00.000
00000 (0000000000 Venture Capital-Backed Laval, Canada 00 0000 0000000000 0000
00000 0000000 Formerly VC-backed Hayward, CA 000 00000 000000&0 00000
00000000 00000000 Venture Capital-Backed Morrisville, NC 0 000.00 00000000000 000.00
You’re viewing 5 of 10 competitors. Get the full list »

Ulthera Patents

Ulthera Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019385902-A1 Systems and methods for enhancing efficacy of ultrasound treatment Pending 30-Nov-2018 00000000
EP-3886981-A1 Systems and methods for enhancing efficacy of ultrasound treatment Pending 30-Nov-2018 00000000
CA-3116332-A1 Systems and methods for enhancing efficacy of ultrasound treatment Pending 30-Nov-2018 00000000
US-20210093898-A1 Systems and methods for combined cosmetic treatment of cellulite with ultrasound Pending 20-Feb-2018 00000000
JP-2021511089-A Systems and methods for simultaneous multifocal ultrasound therapy in multiple dimensions Pending 26-Jan-2018 A61N7/02
To view Ulthera’s complete patent history, request access »

Ulthera Executive Team (8)

Name Title Board Seat Contact Info
Michael Fritts Vice President & General Manager
You’re viewing 1 of 8 executive team members. Get the full list »

Ulthera Board Members (8)

Name Representing Role Since
Michael Slayton Ph.D Self Founder & Board Member 000 0000
You’re viewing 1 of 8 board members. Get the full list »

Ulthera Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ulthera Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
3i Group PE/Buyout Minority 000 0000 000000 0
Apposite Capital PE/Buyout Minority 000 0000 000000 0
Hercules Finance Venture Capital Minority 000 0000 000000 0
New Enterprise Associates Venture Capital Minority 000 0000 000000 0
To view Ulthera’s complete investors history, request access »

Ulthera Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000 03-Feb-2014 0000000000 Therapeutic Devices
To view Ulthera’s complete acquisitions history, request access »